Eledon Pharmaceuticals, Inc.
ELDN
$3.56
-$0.03-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -310.26% | -26.07% | -268.26% | 113.49% | 85.28% |
| Total Depreciation and Amortization | -- | -- | 281.91% | 90.96% | 27.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 109.91% | -20.94% | 142.21% | -221.92% | -144.93% |
| Change in Net Operating Assets | -24.82% | -12.15% | -84.52% | 1,475.79% | 266.18% |
| Cash from Operations | -26.20% | -31.88% | -79.71% | -70.27% | -42.37% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 116.87% | 115.35% | -25.44% | -64.79% | -114.64% |
| Cash from Investing | 116.87% | 115.35% | -25.44% | -64.79% | -114.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -59.82% | -59.70% | 50.47% | 77.99% | 304.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -59.82% | -59.70% | 50.47% | 77.99% | 304.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -182.51% | -85.83% | -199.94% | -36.16% | 106.96% |